Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927362 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDH15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC648761 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUFU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLIN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZIC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100133669 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928002 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on